Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.

Frauger E, Pauly V, Natali F, Pradel V, Reggio P, Coudert H, Thirion X, Micallef J.

CNS Drugs. 2011 May;25(5):415-24. doi: 10.2165/11587640-000000000-00000.

PMID:
21476612
2.

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database.

Frauger E, Pauly V, Thirion X, Natali F, Pradel V, Reggio P, Rouby F, Coudert H, Micallef J.

Int Clin Psychopharmacol. 2009 Nov;24(6):318-24. doi: 10.1097/YIC.0b013e328330ae4b.

PMID:
19820405
3.

Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database.

Cepeda MS, Fife D, Berwaerts J, Yuan Y, Mastrogiovanni G.

Drugs R D. 2014 Sep;14(3):205-11. doi: 10.1007/s40268-014-0058-4.

4.

Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.

Ehrhardt C, Boucherie Q, Pauly V, Braunstein D, Ronflé E, Thirion X, Frauger E, Micallef J.

Therapie. 2017 Dec;72(6):635-641. doi: 10.1016/j.therap.2017.05.005. Epub 2017 Jul 21.

PMID:
29061293
5.

Misuse of Methylphenidate.

Clemow DB.

Curr Top Behav Neurosci. 2017;34:99-124. doi: 10.1007/7854_2015_426. Review.

PMID:
26695166
6.

Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.

Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC.

Drug Saf. 2012 Apr 1;35(4):325-34. doi: 10.2165/11596600-000000000-00000.

PMID:
22339505
7.

The potential for misuse and abuse of medications in ADHD: a review.

Clemow DB, Walker DJ.

Postgrad Med. 2014 Sep;126(5):64-81. doi: 10.3810/pgm.2014.09.2801. Review.

PMID:
25295651
8.

Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S.

J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1. Review.

PMID:
18174822
9.

Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.

Treceño C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):435-41. doi: 10.1002/pds.2348. Epub 2012 Jan 17.

PMID:
22253017
10.

Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

Sembower MA, Ertischek MD, Buchholtz C, Dasgupta N, Schnoll SH.

J Addict Dis. 2013;32(1):26-38. doi: 10.1080/10550887.2012.759880.

11.

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Kollins SH.

J Atten Disord. 2008 Sep;12(2):115-25. doi: 10.1177/1087054707311654. Epub 2008 Jan 11. Review.

PMID:
18192623
12.

Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.

Chen CY, Yeh HH, Fang SY, Wu EC, Chang IS, Lin KM.

Psychiatr Serv. 2012 Oct;63(10):1011-8.

PMID:
22911441
14.

The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.

Pottegård A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI.

Eur J Clin Pharmacol. 2012 Oct;68(10):1443-50. doi: 10.1007/s00228-012-1265-y. Epub 2012 Mar 21.

PMID:
22434389
15.
17.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

18.

Deviant patterns of methylphenidate use in adults: a Danish nationwide registry-based drug utilization study.

Rasmussen L, Zoëga H, Hallas J, Pottegård A.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1189-96. doi: 10.1002/pds.3852. Epub 2015 Aug 16. Erratum in: Pharmacoepidemiol Drug Saf. 2017 Dec;26(12 ):1571-1573.

PMID:
26278467
19.

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Epstein T, Patsopoulos NA, Weiser M.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD005041.

PMID:
25230710
20.

Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area.

Peyriere H, Nogue E, Eiden C, Frauger E, Charra M, Picot MC; List of investigators.

Fundam Clin Pharmacol. 2016 Oct;30(5):466-75. doi: 10.1111/fcp.12210. Epub 2016 Aug 18.

PMID:
27315486

Supplemental Content

Support Center